Postoperative Complications in Colorectal Surgery: Could Serum Calprotectin Be the Game-Changer?
Postoperative infections are a leading cause of morbidity and mortality in colorectal surgery, with anastomotic leakage (AL) being a particularly devastating complication. Early detection is crucial, but current biomarkers like white blood cell count, C-reactive protein (CRP), lactate, and procalcitonin (PCT) have limitations. But what if there was a more specific marker for intestinal inflammation?
Enter serum calprotectin (CIS), a protein released by neutrophils during inflammation. This pilot study investigates CIS as a potential biomarker for postoperative complications in colorectal surgery, comparing its dynamics to established markers.
Here's the crux: While CIS showed promise in identifying complications, particularly in patients with malignant disease, its superiority over CRP and WBC remains unclear. And this is the part most people miss: The study highlights the need for larger trials to validate CIS's role, especially considering its higher cost and longer processing time compared to conventional tests.
The controversy lies in: Should we invest in further research on CIS despite its current limitations, or focus on optimizing existing biomarkers and clinical assessment? This study opens a debate on the future of postoperative complication detection, urging us to consider the balance between specificity, accessibility, and cost-effectiveness. What's your take?
